Insurance Delays in the Approval of Biologic Medications for Patients With Psoriasis and Psoriatic Arthritis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Insurance delays in the approval of biologic medications for patients with psoriasis and psoriatic arthritis
Arch Dermatol Res 2022 Nov 14;[EPub Ahead of Print], T Vazquez, M Forouzandeh, D Lin, F Chin, M Perez, A Caban-Martinez, A MaderalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.